Lyell Wealth Management LP Has $1.12 Million Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Lyell Wealth Management LP decreased its position in DocuSign, Inc. (NASDAQ:DOCU) by 10.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 18,801 shares of the company’s stock after selling 2,097 shares during the period. Lyell Wealth Management LP’s holdings in DocuSign were worth $1,118,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Assenagon Asset Management S.A. raised its stake in shares of DocuSign by 321.3% in the third quarter. Assenagon Asset Management S.A. now owns 214,877 shares of the company’s stock valued at $9,025,000 after purchasing an additional 163,875 shares in the last quarter. Executive Wealth Management LLC bought a new stake in DocuSign in the 3rd quarter valued at $1,000,000. SG Americas Securities LLC increased its holdings in DocuSign by 93.1% in the 4th quarter. SG Americas Securities LLC now owns 78,423 shares of the company’s stock valued at $4,662,000 after buying an additional 37,801 shares during the period. Charles Schwab Investment Management Inc. raised its stake in shares of DocuSign by 77.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,215,650 shares of the company’s stock valued at $51,057,000 after buying an additional 531,682 shares in the last quarter. Finally, Grimes & Company Inc. acquired a new stake in shares of DocuSign during the 3rd quarter valued at about $12,047,000. Institutional investors own 77.64% of the company’s stock.

Insider Activity at DocuSign

In other news, Director Peter Solvik sold 15,000 shares of DocuSign stock in a transaction that occurred on Tuesday, April 9th. The shares were sold at an average price of $60.00, for a total transaction of $900,000.00. Following the completion of the sale, the director now owns 783 shares in the company, valued at approximately $46,980. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, CEO Allan C. Thygesen sold 7,680 shares of the company’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the sale, the chief executive officer now owns 111,767 shares in the company, valued at $6,847,964.09. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Peter Solvik sold 15,000 shares of the business’s stock in a transaction dated Tuesday, April 9th. The stock was sold at an average price of $60.00, for a total value of $900,000.00. Following the transaction, the director now owns 783 shares of the company’s stock, valued at $46,980. The disclosure for this sale can be found here. Insiders have sold a total of 54,871 shares of company stock worth $3,176,199 over the last 90 days. Insiders own 17.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on DOCU shares. Morgan Stanley raised shares of DocuSign from an “underweight” rating to an “equal weight” rating and increased their price target for the stock from $49.00 to $64.00 in a research report on Tuesday, January 16th. Royal Bank of Canada reissued a “sector perform” rating and issued a $59.00 target price on shares of DocuSign in a report on Friday, April 12th. Wells Fargo & Company decreased their price target on DocuSign from $55.00 to $45.00 and set an “underweight” rating on the stock in a research note on Monday, February 5th. JMP Securities reiterated a “market outperform” rating and set a $84.00 price objective on shares of DocuSign in a research note on Friday, April 12th. Finally, UBS Group raised DocuSign from a “sell” rating to a “neutral” rating and lifted their price objective for the company from $48.00 to $62.00 in a report on Friday, April 12th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $60.25.

DocuSign Stock Performance

DOCU traded down $0.06 during midday trading on Thursday, hitting $57.23. The company had a trading volume of 604,856 shares, compared to its average volume of 3,281,858. DocuSign, Inc. has a twelve month low of $38.11 and a twelve month high of $64.76. The firm’s 50-day simple moving average is $56.23 and its 200-day simple moving average is $52.51. The company has a market capitalization of $11.76 billion, a PE ratio of 157.23, a P/E/G ratio of 4.96 and a beta of 0.89.

DocuSign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, March 7th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.06. The firm had revenue of $712.39 million during the quarter, compared to analysts’ expectations of $698.05 million. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. As a group, sell-side analysts anticipate that DocuSign, Inc. will post 0.86 EPS for the current fiscal year.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.